Xiangqun Liu

ORCID：0009-0003-5100-7413

发表论文 47 篇 · 总被引 726 次 · h-index 15

代表论文

• MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc (2020 · Biomedicine & Pharmacotherapy · 被引 65)
• Exploring multidrug-resistant Klebsiella pneumoniae antimicrobial resistance mechanisms through whole genome sequencing analysis (2023 · BMC Microbiology · 被引 47)
• Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level (2018 · BioMed Research International · 被引 47)
• Detection of AmpC β-lactamases in Acinetobacter baumannii in the Xuzhou region and analysis of drug resistance (2015 · Experimental and Therapeutic Medicine · 被引 29)
• Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer (2023 · Clinical & Translational Oncology · 被引 28)
• Detection and genotype analysis of AmpC β-lactamase in Klebsiella pneumoniae from tertiary hospitals (2016 · Experimental and Therapeutic Medicine · 被引 26)